NanoViricides Inc (NNVC) Company Profile & Statistics

NanoViricides Inc
NNVC
(AMEX)
N/A
1.12
-0.08 (-6.67%)
in:usd•As of: May 03, 2024 13:01 UTC -4
Open
1.12
High
1.12
Low
1.12

About NanoViricides Inc

CEO

Anil Diwan

Auditor

EisnerAmper LLP

Sector

health technology

Employees

Headquarters

1 controls drive

shelton, ct 06484, united states

Website

www.nanoviricides.com

Industry

pharmaceuticals major

Share Holders

152

Company Overview

NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development of drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides, Inc. is headquartered in West Haven, Connecticut.

NanoViricides Inc Statistics

Valuation Measures

Market Capitalization ²	13.19M
Enterprise Value	7.95M
Enterprise Value/EBITDA (ttm)	-0.89
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.12
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-63.97%
Return on Invested Capital (ttm)	-63.95%
Return on Assets (ttm)	-58.21%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-8.95M
Net Income Avi to Common (ttm)	-9.36M
Diluted EPS (ttm)	-0.81

Share Statistics

Beta (5Y Monthly)	0.70
52-Week Change	-7.44%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	11.78M
Dividend Yield	0.00%
Float ⁴	11.24M
% Held by Insiders	4.60%
% Held by Institutions	10.30%

Balance Sheet

Total Cash (mrq)	5.25M
Total Cash Per Share (mrq)	0.45
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	5.59%
Quick Ratio (mrq)	5.59%
Book Value Per Share (mrq)	1.06

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.25
Free Cash Flow (ytd)	-2.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NanoViricides Inc

Trade With A Regulated Broker